As of 2025-01-13, the Intrinsic Value of Aldeyra Therapeutics Inc (ALDX) is
-3.76 USD. This ALDX valuation is based on the model Peter Lynch Fair Value.
With the current market price of 4.94 USD, the upside of Aldeyra Therapeutics Inc is
-176.14%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-3.76 USD
Intrinsic Value
ALDX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-3.76 - -3.76 |
-3.76 |
-176.14% |
| P/E |
(11.43) - (12.41) |
(10.31) |
-308.6% |
| DDM - Stable |
(6.01) - (19.97) |
(12.99) |
-362.9% |
| DDM - Multi |
(4.85) - (12.71) |
(7.04) |
-242.5% |
ALDX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
294.18 |
| Beta |
0.69 |
| Outstanding shares (mil) |
59.55 |
| Enterprise Value (mil) |
241.34 |
| Market risk premium |
4.60% |
| Cost of Equity |
10.08% |
| Cost of Debt |
5.00% |
| WACC |
9.76% |